Other Respiratory System O.R. Procedures DRG Reimbursement

DRG 168 includes other respiratory system operating room procedures without a Complication or Comorbidity or Major Complication or Comorbidity, typically covering lower-severity thoracic operations. Proper assignment affects inpatient reimbursement because it determines the bundled Diagnosis-Related Group payment rate under Medicare.

DRG 168 Overview

DRG 168 covers inpatient admissions for other respiratory system operations performed in an operating room without the presence of a Complication or Comorbidity or Major Complication or Comorbidity. This Diagnosis-Related Group applies to procedures such as diagnostic or minor therapeutic thoracic surgeries that do not carry higher-risk secondary diagnoses. It matters for Medicare payment because classification into this group influences the bundled payment amount and hospital reimbursement for the episode of care. Accurate coding and documentation determine whether an admission is assigned to this lower-severity payment category.

Acute perioperative airway management trials: studies evaluating interventions to reduce intraoperative and immediate postoperative respiratory complications in patients undergoing non-major respiratory surgeries (for example, bronchoscopic interventions, pleural procedures, or minor thoracic surgeries) without major comorbid conditions. These trials enroll adults who require airway manipulation or short-duration thoracic procedures and measure outcomes such as perioperative hypoxemia, need for unplanned intensive care transfer, and duration of mechanical ventilation. Findings are relevant to clinicians and payers because reducing short-term respiratory complications can shorten length of stay and lower costs associated with unplanned escalation of care in this DRG.
Comparative effectiveness research of procedural approaches and anesthesia strategies: randomized or observational studies comparing different surgical techniques (for example, minimally invasive versus open approaches when applicable), anesthesia modalities (general anesthesia with endotracheal intubation versus monitored anesthesia care), or perioperative analgesia protocols for patients undergoing other respiratory system O.R. procedures without major complications. These studies focus on patients judged to be low or moderate risk (no CC/MCC), assessing outcomes such as postoperative pulmonary function, pain control, complication rates, and time to discharge. Results inform providers and payers about which approaches optimize recovery and resource use for this specific DRG population, guiding protocol selection and reimbursement policy for efficiently delivered care.
Post-discharge recovery and readmission prevention studies: prospective cohort studies or intervention trials targeting early outpatient follow-up, pulmonary rehabilitation initiation, or home-based monitoring for patients after non-complicated respiratory procedures to reduce 30-day readmissions and functional decline. These studies enroll patients classified without CC/MCC who are discharged directly home, evaluating symptom trajectories, adherence to follow-up, and healthcare utilization after discharge. Evidence from this research helps payers and health systems design cost-effective care pathways and transitional care programs to prevent avoidable readmissions and improve patient-centered outcomes in this DRG.

Acute perioperative airway management trials: studies evaluating interventions to reduce intraoperative and immediate postoperative respiratory complications in patients undergoing non-major respiratory surgeries (for example, bronchoscopic interventions, pleural procedures, or minor thoracic surgeries) without major comorbid conditions. These trials enroll adults who require airway manipulation or short-duration thoracic procedures and measure outcomes such as perioperative hypoxemia, need for unplanned intensive care transfer, and duration of mechanical ventilation. Findings are relevant to clinicians and payers because reducing short-term respiratory complications can shorten length of stay and lower costs associated with unplanned escalation of care in this DRG.
Comparative effectiveness research of procedural approaches and anesthesia strategies: randomized or observational studies comparing different surgical techniques (for example, minimally invasive versus open approaches when applicable), anesthesia modalities (general anesthesia with endotracheal intubation versus monitored anesthesia care), or perioperative analgesia protocols for patients undergoing other respiratory system O.R. procedures without major complications. These studies focus on patients judged to be low or moderate risk (no CC/MCC), assessing outcomes such as postoperative pulmonary function, pain control, complication rates, and time to discharge. Results inform providers and payers about which approaches optimize recovery and resource use for this specific DRG population, guiding protocol selection and reimbursement policy for efficiently delivered care.
Post-discharge recovery and readmission prevention studies: prospective cohort studies or intervention trials targeting early outpatient follow-up, pulmonary rehabilitation initiation, or home-based monitoring for patients after non-complicated respiratory procedures to reduce 30-day readmissions and functional decline. These studies enroll patients classified without CC/MCC who are discharged directly home, evaluating symptom trajectories, adherence to follow-up, and healthcare utilization after discharge. Evidence from this research helps payers and health systems design cost-effective care pathways and transitional care programs to prevent avoidable readmissions and improve patient-centered outcomes in this DRG.

OpenPayer

Summary & Overview

Other Respiratory System O.R. Procedures without CC/MCC: Inpatient Reimbursement Overview

DRG 168 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes